Event

Job opportunity

Mentoring

Board Member

Other

Womenat

This&nbsp;site&nbsp;uses&nbsp;cookies&nbsp;to&nbsp;improve&nbsp;your&nbsp;experience.&nbsp;By&nbsp;clicking,&nbsp;you&nbsp;agree&nbsp;to&nbsp;our&nbsp;Privacy&nbsp;Policy.

thumbnail_blob

blob

Yuliya Gevrenova is an associate in the Life Sciences Practice Group. She advises clients across a wide range of regulatory, compliance and procedural issues, focusing on EU and Public International law.


March  2022 - Present •  Brussels, Belgium

Associate

Covington & Burling 

Brussels

Zwijndrecht

Zwevegem

Zottegem

Zonhoven

Zoersel

Zemst

Zele

Zedelgem

Zaventem

Wuustwezel

Willebroek

Wevelgem

Wetteren

Westerlo

Wervik

Wavre

Waterloo

Waregem

Walcourt

Visé

Vilvoorde

Verviers

Turnhout

Tubize

Tournai

Torhout

Tongeren

Tienen

Tielt

Tessenderlo

Tervuren

Temse

Stekene

Stabroek

Soumagne

Soignies

Sint-Truiden

Sint-Pieters-Leeuw

Sint-Niklaas

Sint-Kruis

Sint-Katelijne-Waver

Sint-Gillis-Waas

Sint-Genesius-Rode

Seraing

Schoten

Schilde

Saint-Nicolas

Saint-Ghislain

Rotselaar

Ronse

Roeselare

Rixensart

Riemst

Ranst

Quaregnon

Puurs

Putte

Poperinge

Pont-à-Celles

Péruwelz

Peer

Overijse

Oupeye

Oudenaarde

Oostkamp

Ostend

Nivelles

Ninove

Nijlen

Neerpelt

Namur

Mouscron

Mortsel

Morlanwelz-Mariemont

Mons

Middelkerke

Merelbeke

Menen

Meise

Mechelen

Marche-en-Famenne

Manage

Maldegem

Maasmechelen

Maaseik

Louvain-la-Neuve

Londerzeel

Lommel

Lokeren

Lochristi

Lille

Lier

Liège

Leuven

Lessines

Lede

Lebbeke

Lanaken

La Louvière

medium_Brussels.jpg

small_Brussels.jpg

thumbnail_Brussels.jpg

Brussels.jpg

Harvard Law School

This W@LifeSciences event aims to provide an opportunity to take stock of the outcomes of the World Health Organisation (WHO) Pandemic Treaty&nbsp;negotiations and of the World Health Assembly&nbsp;(WHA) decision, and consider the implications globally, for health security in Europe, as well as for industry.&nbsp;17:00 Doors open&nbsp;17:30 Discussion chaired by Laura Batchelor,&nbsp; Board Member of W@LifeSciences<ul><li>Maggie de Block –&nbsp;Former Belgian Minister of Health and MP, Member of the Global Leaders Group on Antimicrobial Resistance</li><li>Yuliya Gevrenova – Associate in the Life Sciences Practice Group, Covington &amp; Burling</li><li>Martin Widstam – Delegation of the European Union to the United Nations, EEAS</li><li>Dr Nelson Dordelly Rosales – Advocacy &amp; International Relations Specialist at FOUR PAWS International &nbsp;</li></ul>&nbsp;18:40 Networking drinks&nbsp;The event, hosted by Covington &amp; Burling, is open to everyone regardless of gender. Advance registration required: first come, first served.&nbsp;More about the event theme:The idea for a WHO Pandemic Treaty was born out of the Covid-19 pandemic which revealed the global challenges in preparing for and responding to pandemic health emergencies. Many of the issues encountered in the pandemic fell beyond the scope of the existing International Health Regulations (IHR), such as the equitable access to pandemic- related health products and the sharing of pathogen and genome sequencing data (GSD). The Intergovernmental Negotiating Body (INB) was mandated to deliver a Pandemic Treaty to address these gaps and provide a framework for WHO Member States to collaborate in the event of a pandemic. Over the last two years, negotiations for the treaty have been challenging. It has shown that building a system that provides equitable access to pandemic-related health products is a complex issue that requires agreement on a range of topics such as Pathogen Access and Benefit Sharing, Supply Chain and Logistics, Research and Development, Tech Transfer, OneHealth, Financing, among others. After it proved impossible for an agreement on the treaty to be reached prior to the 77th World Health Assembly (WHA) in May, the deadline has now been extended by one year. The international community needs to use this opportunity to try and put aside their differences, particularly on pathogen access, governance and accountability. The response to the next pandemic will require the international community to take proactive steps for real change.

Solutions for Bridging the Gap to Equitable Access to Pandemic-Related Medical Products